Modifiable Risk Factors Tied to Young-Onset Dementia
By Lori Solomon HealthDay Reporter
THURSDAY, Dec. 28, 2023 -- Several modifiable factors are associated with a higher risk for young-onset dementia (YOD), according to a study published online Dec. 26 in JAMA Neurology.
Stevie Hendriks, Ph.D., from Maastricht University in the Netherlands, and colleagues examined 39 factors associated with the incidence of YOD from the literature using data from 356,052 participants younger than 65 years in the U.K. Biobank (baseline assessment 2006 to 2010 and follow-up until March 31, 2021).
The researchers found that during the study period, there were 485 incident YOD cases (51.8 percent men), yielding an incidence rate of 16.8 per 100,000 person-years. Fifteen of the 39 factors were significantly associated with a higher YOD risk, including lower formal education, lower socioeconomic status, carrying two apolipoprotein ε4 alleles, no alcohol use, alcohol use disorder, social isolation, vitamin D deficiency, high C-reactive protein levels, lower handgrip strength, hearing impairment, orthostatic hypotension, stroke, diabetes, heart disease, and depression.
"In this study, several factors, mostly modifiable, were associated with a higher risk of YOD," the authors write. "These modifiable risk factors should be incorporated in future dementia prevention initiatives and raise new therapeutic possibilities for YOD."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
Even Exercising a Few Times a Week Cuts Later Dementia Risk
THURSDAY, Oct. 31, 2024 -- The "weekend warrior" physical activity pattern is associated with a reduced risk for mild dementia over time, according to a study published online...
ED Visit Rate 36.1 per 1,000 Older Adults With Alzheimer Disease
TUESDAY, Oct. 29, 2024 -- For adults aged 65 years and older with Alzheimer disease, the emergency department visit rate was 36.1 visits per 1,000 adults in 2020 to 2022...
Cognitive Therapy, Modafinil, Combo All Beneficial for Multiple Sclerosis Fatigue
FRIDAY, Oct. 25, 2024 -- Cognitive behavioral therapy (CBT), modafinil, and their combination are equally beneficial for multiple sclerosis fatigue, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.